Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Anemia

Free Subscription Articles published in Int J Hematol Retrieve available abstracts of 58 articles: HTML format

Single Articles

November 2026
1. ISODA A
   Hb constant spring as a diagnostic challenge in mild microcytic anemia.
   Int J Hematol. 2026 Nov 3. doi: 10.1007/s12185-026-04311.
   PubMed    
   
   
   
2. TULSIYAN A, Bhattacharya S, Singh A, Nilay M, et al
   Metabolic mimic of inherited bone marrow failure: LMBRD1 (cblF) deficiency in an infant.
   Int J Hematol. 2026;124:741-746.
   PubMed     Abstract available
   
   
   July 2026
3. JANG JH, Kwong YL, Issaragrisil S, Hosokawa K, et al
   Evidence- and opinion-based consensus from Delphi round 1 of the Asian aplastic anemia recommendation development.
   Int J Hematol. 2026 Jul 22. doi: 10.1007/s12185-026-04240.
   PubMed     Abstract available
   
   
   June 2026
4. HOSOKAWA K
   Immunological links between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
   Int J Hematol. 2026 Jun 8. doi: 10.1007/s12185-026-04236.
   PubMed     Abstract available
   
   
   
5. SAKURAI M, Ueda Y, Obara N, Kroes M, et al
   Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world survey.
   Int J Hematol. 2026;123:837-847.
   PubMed     Abstract available
   
   
   May 2026
6. MORITA Y, Tsuji Y, Yasukawa T, Mitani K, et al
   Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.
   Int J Hematol. 2026 May 18. doi: 10.1007/s12185-026-04227.
   PubMed     Abstract available
   
   
   April 2026
7. BAYEWITZ A, Pillarisetty SS, Moeini Nia F
   A case of SCD controlled by IMiDs and hydroxyurea.
   Int J Hematol. 2026;123:607-610.
   PubMed     Abstract available
   
   
   
8. NOGUCHI Y, Mori T, Onishi Y, Nakamura Y, et al
   Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.
   Int J Hematol. 2026;123:600-606.
   PubMed     Abstract available
   
   
   March 2026
9. SATO S, Sawazaki E, Tsunoda S, Kamata W, et al
   Efficacy and safety of romiplostim with horse anti-thymocyte globulin and cyclosporine in acquired aplastic anemia.
   Int J Hematol. 2026 Mar 11. doi: 10.1007/s12185-026-04188.
   PubMed     Abstract available
   
   
   January 2026
10. KAYA H, Hamada M, Murayama Y, Mochizuki K, et al
    Micafungin-induced hemolytic anemia: a case report and investigation of anti-micafungin antibody prevalence.
    Int J Hematol. 2026 Jan 28. doi: 10.1007/s12185-026-04161.
    PubMed     Abstract available
    
    
    December 2025
11. BASAK B, Biswas P, Dey S, Paul A, et al
    Iron deficiency anemia perturbs erythrocyte morphology and may promote eryptosis.
    Int J Hematol. 2025 Dec 4. doi: 10.1007/s12185-025-04126.
    PubMed     Abstract available
    
    
    November 2025
12. KOMATSU N, Ito K, Arita K, Mitobe Y, et al
    Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate.
    Int J Hematol. 2025 Nov 14. doi: 10.1007/s12185-025-04108.
    PubMed     Abstract available
    
    
    
13. MANGANAS K, Delicou S, Hadziyannis E, Giannouli S, et al
    Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease.
    Int J Hematol. 2025;122:637-646.
    PubMed     Abstract available
    
    
    September 2025
14. ASWAD HA, Haleem AA, Eissaa AA
    Late renal, liver, endocrine, and cardiac outcomes of bone marrow transplantation in Kurdish children with beta-thalassemia major.
    Int J Hematol. 2025 Sep 19. doi: 10.1007/s12185-025-04067.
    PubMed     Abstract available
    
    
    August 2025
15. GROVER P, S A
    Efficacy of alternate day versus daily oral iron therapy in children with iron deficiency anemia: a randomized controlled trial.
    Int J Hematol. 2025 Aug 17. doi: 10.1007/s12185-025-04048.
    PubMed     Abstract available
    
    
    July 2025
16. YOON SS, Chen CC, Lee SE, Chang H, et al
    Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.
    Int J Hematol. 2025 Jul 21. doi: 10.1007/s12185-025-04037.
    PubMed     Abstract available
    
    
    June 2025
17. IMASHUKU S, Kazuma Y, Chonabayashi K, Shimazu Y, et al
    Myelodysplastic syndrome with ring chromosomes in a case of dehydrated hereditary stomatocytosis 1 (DHS1).
    Int J Hematol. 2025;121:857-861.
    PubMed     Abstract available
    
    
    May 2025
18. WANG X, Qin X, Luo C, Luo C, et al
    Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemia.
    Int J Hematol. 2025 May 23. doi: 10.1007/s12185-025-03971.
    PubMed     Abstract available
    
    
    April 2025
19. CHARITAKI E, Liapis K
    Spherocytic hemolytic anemia caused by Clostridium perfringens.
    Int J Hematol. 2025 Apr 15. doi: 10.1007/s12185-025-03993.
    PubMed    
    
    
    
20. TOKUSHIGE J, Taoka K, Nishikawa M, Jona M, et al
    Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2025;121:543-546.
    PubMed     Abstract available
    
    
    
21. RAO M, Luo W, Wu B
    The medium-fluorescence reticulocyte ratio is an independent predictor of G6PD deficiency neonates.
    Int J Hematol. 2025;121:526-532.
    PubMed     Abstract available
    
    
    February 2025
22. YAMAMOTO R, Hiramoto N, Nagai Y, Ishikawa T, et al
    Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience.
    Int J Hematol. 2025 Feb 12. doi: 10.1007/s12185-025-03940.
    PubMed     Abstract available
    
    
    
23. MOMBO LE, Moreau BD, Bisseye C, Mikelet Boussoukou IP, et al
    Screening for sickle cell anemia in two populations of eastern Gabon using alkaline electrophoresis and hemoglobin level combined with leukocyte count.
    Int J Hematol. 2025 Feb 5. doi: 10.1007/s12185-025-03934.
    PubMed     Abstract available
    
    
    January 2025
24. KOSUGI H, Fujisaki T, Iwasaki H, Shinagawa A, et al
    A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
    Int J Hematol. 2025;121:68-78.
    PubMed     Abstract available
    
    
    
25. EDAHIRO Y, Komatsu N
    Iron deficiency and phlebotomy in patients with polycythemia vera.
    Int J Hematol. 2025;121:39-44.
    PubMed     Abstract available
    
    
    December 2024
26. EGUCHI K, Ishimura M, Ohga S, Endo S, et al
    Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia.
    Int J Hematol. 2024 Dec 27. doi: 10.1007/s12185-024-03903.
    PubMed     Abstract available
    
    
    
27. MOMOEDA M, Ito K, Inoue S, Shibahara H, et al
    Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia.
    Int J Hematol. 2024 Dec 26. doi: 10.1007/s12185-024-03905.
    PubMed     Abstract available
    
    
    
28. MIYAKAWA Y, Sato E, Ogawa Y, Nishimura JI, et al
    Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease.
    Int J Hematol. 2024;120:656-664.
    PubMed     Abstract available
    
    
    
29. SATO K, Nakamura Y, Hara R, Kayama R, et al
    Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab.
    Int J Hematol. 2024;120:735-742.
    PubMed     Abstract available
    
    
    November 2024
30. AL-JUBOURI AM, Eliwa A, Haithm Y, Al-Qahtani N, et al
    Relationship between hemoglobinopathies and male infertility: a scoping review.
    Int J Hematol. 2024;120:566-574.
    PubMed     Abstract available
    
    
    September 2024
31. SAEIDNIA M, Shadfar F, Sharifi S, Babashahi M, et al
    Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach.
    Int J Hematol. 2024;120:271-277.
    PubMed     Abstract available
    
    
    May 2024
32. KOSUGI M, Takezawa R, Shiota S, Tsuchikawa M, et al
    Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments.
    Int J Hematol. 2024 May 28. doi: 10.1007/s12185-024-03801.
    PubMed     Abstract available
    
    
    April 2024
33. WU LS, Luo X, Tan M, Zhang LJ, et al
    Prevalence of thalassemia-carrier couples and fertility risk assessment.
    Int J Hematol. 2024;119:374-382.
    PubMed     Abstract available
    
    
    March 2024
34. SAWADA Y, Sakamoto K, Tsukamura A, Sawai C, et al
    Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet.
    Int J Hematol. 2024 Mar 25. doi: 10.1007/s12185-024-03759.
    PubMed     Abstract available
    
    
    
35. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2024 Mar 6. doi: 10.1007/s12185-024-03739.
    PubMed    
    
    
    
36. OBARA N, Usuki K, Hayashi T, Fujii M, et al
    Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors.
    Int J Hematol. 2024;119:255-264.
    PubMed     Abstract available
    
    
    
37. NAKAO S
    Diagnosis of immune pathophysiology in patients with bone marrow failure.
    Int J Hematol. 2024;119:231-239.
    PubMed     Abstract available
    
    
    February 2024
38. SCHEINBERG P
    Progress in medical therapy in aplastic anemia: why it took so long?
    Int J Hematol. 2024 Feb 26. doi: 10.1007/s12185-024-03713.
    PubMed     Abstract available
    
    
    
39. ONISHI Y
    Aplastic anemia: history and recent developments in diagnosis and treatment.
    Int J Hematol. 2024 Feb 4. doi: 10.1007/s12185-024-03715.
    PubMed     Abstract available
    
    
    January 2024
40. IGUCHI A, Uchiyama T, Fujimori K, Gocho Y, et al
    HLA-haploidentical T-cell receptor alphabetaT/B-cell-depleted stem cell transplantation for Fanconi anemia.
    Int J Hematol. 2024 Jan 16. doi: 10.1007/s12185-023-03703.
    PubMed     Abstract available
    
    
    
41. KASHIWAGI H, Kuwana M, Murata M, Shimada N, et al
    Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.
    Int J Hematol. 2024;119:1-13.
    PubMed     Abstract available
    
    
    December 2023
42. MAKITA S, Ota S, Mishima Y, Usuki K, et al
    Japanese phase Ib study of the oral PI3K-delta and -gamma inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Int J Hematol. 2023 Dec 27. doi: 10.1007/s12185-023-03689.
    PubMed     Abstract available
    
    
    
43. ZHENG J, Gao L, Liu H, Xiao P, et al
    Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Int J Hematol. 2023 Dec 21. doi: 10.1007/s12185-023-03676.
    PubMed     Abstract available
    
    
    
44. MIKI K, Ogasawara R, Sugimura S, Sugita J, et al
    A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.
    Int J Hematol. 2023;118:766-771.
    PubMed     Abstract available
    
    
    October 2023
45. SHINN LT, Benitez LL, Perissinotti AJ, Reid JH, et al
    Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
    Int J Hematol. 2023 Oct 26. doi: 10.1007/s12185-023-03670.
    PubMed     Abstract available
    
    
    
46. FUKATSU M, Hamazaki Y, Sato Y, Koyama D, et al
    A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
    Int J Hematol. 2023;118:472-476.
    PubMed     Abstract available
    
    
    
47. NISHIMURA JI, Kawaguchi T, Ito S, Murai H, et al
    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.
    Int J Hematol. 2023;118:419-431.
    PubMed     Abstract available
    
    
    September 2023
48. CHATZIKALIL E, Kattamis A, Diamantopoulos P, Solomou EE, et al
    New-onset aplastic anemia after SARS-CoV-2 vaccination.
    Int J Hematol. 2023 Sep 28. doi: 10.1007/s12185-023-03666.
    PubMed     Abstract available
    
    
    
49. LI H, Wang J, Wang D, Gan Y, et al
    Ten years' experience in prenatal diagnosis of alpha-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.
    Int J Hematol. 2023;118:355-363.
    PubMed     Abstract available
    
    
    
50. USUKI K, Ikezoe T, Ishiyama K, Kanda Y, et al
    Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2023;118:311-322.
    PubMed     Abstract available
    
    
    
51. WANG P, Yang S
    Clonal cytopenia of undetermined significance presenting with multiple duplications of chromosome 1q.
    Int J Hematol. 2023;118:307-308.
    PubMed    
    
    
    July 2023
52. EDAHIRO Y, Ochiai T, Hashimoto Y, Morishita S, et al
    Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Int J Hematol. 2023;118:47-53.
    PubMed     Abstract available
    
    
    May 2023
53. KOBAYASHI M, Mori A, Oda Y, Yokoyama E, et al
    New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2023 May 23:1-6. doi: 10.1007/s12185-023-03618.
    PubMed     Abstract available
    
    
    April 2023
54. SALES RR, Luizon MR
    Effect of haplotypes of functional SNPs related to expression of fetal hemoglobin (HbF) on clinical prognosis of hematological malignancies.
    Int J Hematol. 2023;117:626-627.
    PubMed    
    
    
    
55. YAMANO S, Iguchi A, Ishikawa K, Sakamoto A, et al
    Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome.
    Int J Hematol. 2023;117:622-625.
    PubMed     Abstract available
    
    
    
56. SUZUKI Y, Shiba T
    Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination.
    Int J Hematol. 2023;117:618-621.
    PubMed     Abstract available
    
    
    March 2023
57. YOSHIDA N
    Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia.
    Int J Hematol. 2023 Mar 3. doi: 10.1007/s12185-023-03564.
    PubMed     Abstract available
    
    
    
58. KUBO M, Matsumoto M
    Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Int J Hematol. 2023;117:331-340.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum